Diabetes, Obesity & Metabolism
Canagliflozin linked to urine protein shifts in kidney disease
After one year, 124 urinary proteins changed with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease.After one year, 124 urinary proteins changed with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease.

Case-control · 337 peopleCanagliflozin
Who was studied337 patients with type 2 diabetes and CKD, 1 year, against placebo
What changedUrine levels of 124 proteins changed with canagliflozin compared with placebo
The catchProtein measurements could be distorted by nonspecific aptamer binding and probe cross-reactivity